Literature DB >> 8863680

K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.

N Erill1, M Cuatrecasas, F J Sancho, A Farré, P M Pour, F Lluís, G Capellá.   

Abstract

K-ras and p53 gene alterations are frequently found in human pancreatic carcinomas and cell lines. The aim of this study was to analyze for the presence of K-ras and p53 gene mutations in hamster pancreatic tumors and cell lines. Mutations at the first coding exon of the K-ras gene and in exons V to VIII of the hamster p53 gene were analyzed in six cell lines (H2T, PC1, PC1.2, PC1.0, WD, and PD) and in N-nitroso-bis(2-oxopropyl)amine-induced pancreatic (n = 9) and extra-pancreatic (n = 4) tumors. K-ras mutations were present in seven of the nine pancreatic tumors and in all extra-pancreatic tumors. No p53 mutations were detected in the tumors. All cell lines analyzed contained K-ras mutations. Moreover, four of the six cell lines contained single amino acid substitutions in the p53 gene. Cell lines derived from nitrosamine-induced pancreatic tumors in the hamster contained K-ras and p53 alterations similar to those found in cell lines derived from human pancreatic carcinomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863680      PMCID: PMC1865186     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE.

Authors:  B Budowle; R Chakraborty; A M Giusti; A J Eisenberg; R C Allen
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

2.  K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster.

Authors:  W L Cerny; K A Mangold; D G Scarpelli
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

3.  The cDNA cloning and immunological characterization of hamster p53.

Authors:  Y Legros; P McIntyre; T Soussi
Journal:  Gene       Date:  1992-03-15       Impact factor: 3.688

4.  Activation of K-ras in transplantable pancreatic ductal adenocarcinomas of Syrian golden hamsters.

Authors:  W L Cerny; K A Mangold; D G Scarpelli
Journal:  Carcinogenesis       Date:  1990-11       Impact factor: 4.944

5.  Patterns of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implications.

Authors:  P M Pour; H Egami; Y Takiyama
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

6.  Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats.

Authors:  H J van Kranen; E Vermeulen; L Schoren; J Bax; R A Woutersen; P van Iersel; C F van Kreijl; E Scherer
Journal:  Carcinogenesis       Date:  1991-08       Impact factor: 4.944

7.  The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NR.

Authors:  S Egawa; M Tsutsumi; Y Konishi; M Kobari; S Matsuno; K Nagasaki; H Futami; K Yamaguchi
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

8.  Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas.

Authors:  K W Chang; S Laconi; K A Mangold; S Hubchak; D G Scarpelli
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

9.  Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors.

Authors:  G Capella; S Cronauer-Mitra; M A Pienado; M Perucho
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

10.  Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

Authors:  C M Barton; S L Staddon; C M Hughes; P A Hall; C O'Sullivan; G Klöppel; B Theis; R C Russell; J Neoptolemos; R C Williamson
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more
  1 in total

1.  MiRNA-21-5p Accelerates EMT and Inhibits Apoptosis of Laryngeal Carcinoma via Inhibiting KLF6 Expression.

Authors:  Yanjun Xu
Journal:  Biochem Genet       Date:  2022-06-27       Impact factor: 1.890

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.